文献速递腹部技术与安全MR

全身炎症生物标志物联合MR影像特征术前预测肝细胞癌微血管侵犯

Preoperative application of systemic inflammatory biomarkers combined with MR imaging features in predicting microvascular invasion of hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2022-03-10

回顾性纳入2018年1月至2020年12月156例经组织学确诊的肝细胞癌患者,记录术前临床炎症生物标志物和MR影像并分别评估为炎症评分与影像特征评分。 logistic回归筛选出4项影像评分和2项炎症评分与微血管侵犯显著相关,构建的列线图AUC为0.868(95%CI 0.806-0.931);在影像评分基础上加入炎症评分使模型敏感度从60.9%提高到80.4%,并在决策曲线分析中带来净获益。

要点

  • 肿瘤较大、边缘不光滑、卫星结节、瘤周强化4项MR征象与微血管侵犯显著相关。
  • 中性粒细胞-淋巴细胞比值升高和预后营养指数降低2项炎症指标与微血管侵犯显著相关。
  • 影像评分加入炎症评分后模型敏感度从60.9%提高到80.4%,决策曲线分析显示净获益。

核心结论

  • 全身炎症生物标志物是补充工具,在常规影像评估基础上为预测肝细胞癌患者微血管侵犯提供额外获益。

研究设计与样本

  • 回顾性队列,主要队列纳入2018年1月至2020年12月156例经组织学确诊的肝细胞癌患者,记录术前临床炎症生物标志物和MR影像,分别评估为炎症评分(Inflam-score)和影像特征评分(Radio-score),经单因素分析确定6项炎症评分和12项影像评分,采用logistic回归筛选微血管侵犯危险因素并建立预测列线图,以决策曲线分析评估炎症评分对影像评分的增量价值。

关键影像表现/征象

  • 肿瘤较大、肿瘤边缘不光滑、存在卫星结节、存在瘤周强化4项影像评分与微血管侵犯显著相关(p < 0.05)。

诊断标准与关键数值

  • 基于4项影像评分和2项炎症评分构建的微血管侵犯风险预测列线图AUC为0.868(95% CI 0.806-0.931)。
  • 在影像评分基础上加入炎症评分,ROC曲线分析中模型敏感度从60.9%提高到80.4%。

临床应用与阅片要点

  • 作者认为全身炎症生物标志物是补充工具,可为常规影像评估预测肝细胞癌微血管侵犯提供额外获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate whether systemic inflammatory biomarkers compared with the imaging features interpreted by radiologists can offer complementary value for predicting the risk of microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC).

METHODS: A total of 156 patients with histologically confirmed HCC between Jan 2018 and Dec 2020 were retrospectively enrolled in the primary cohort. Preoperative clinical-inflammatory biomarkers and MR imaging of the patients were recorded and then evaluated as an inflammatory score (Inflam-score) and imaging feature score (Radio-score). Six Inflam-scores and 12 Radio-scores were determined from each patient by univariate analysis. Logistic regression was performed to select risk factors for MVI and establish a predictive nomogram. Decision curve analysis was applied to estimate the incremental value of the Inflam-score to the Radio-score for predicting MVI.

RESULTS: Four Radio-scores and 2 Inflam-scores, namely, larger tumor size, non-smooth tumor margin, presence of satellite nodules, presence of peritumoral enhance, higher neutrophil-lymphocyte ratio (NLR), and lower prognostic nutritional index (PNI), were significantly associated with MVI (p < 0.05). An MVI risk prediction nomogram was then constructed with an area under the curve (AUC) of 0.868 (95% CI 0.806-0.931). Adding Inflam-scores to Radio-scores improved the sensitivity of the model from 60.9 to 80.4% in receiver operating characteristic (ROC) curve analysis and led to a net benefit in decision curve analysis.

CONCLUSION: Systemic inflammatory biomarkers are complementary tools that provide additional benefit to conventional imaging estimation for predicting MVI in HCC patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Xu, Sun, Liu, et al. Preoperative application of systemic inflammatory biomarkers combined with MR imaging features in predicting microvascular invasion of hepatocellular carcinoma. Abdom Radiol (NY). 2022. PMID: 35267069. doi:10.1007/s00261-022-03473-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。